Zoonotic transmission in Tanzania – Professor Sarah Cleaveland, Professor, University of Glasgow, UK

This talk will cover:
• The concepts and principles of One Health.
• The pathogens causing livestock reproductive losses and their consequences for health and livelihoods in Tanzania.
• The potential interventions available to reduce livestock reproductive losses and the opportunities and challenges of implementation.

Professor Sarah Cleaveland graduated as a zoologist and veterinarian and, in 1996, completed her PhD at the London School of Hygiene and Tropical Medicine on the epidemiology of rabies in Tanzania and continues to work towards the global elimination of canine rabies. Prof. Cleaveland is currently based at the University of Glasgow, U.K leading a programme of One Health research with partners in East Africa. This research addresses a range of zoonotic and livestock disease problems affecting human, animal and ecosystem health, providing insights into disease burden, epidemiology, and the design of interventions for disease control and elimination. Professor Cleaveland is a Fellow of the Academy of Medical Sciences and a Fellow of the Royal Society.

Impact of SARS-CoV-2 on fertility, miscarriages and stillbirth – Professor David Baud, Head of Obstetrics, Lausanne University Hospital (CHUV), Switzerland

Professor David Baud, MD PhD, is an obstetrician, specialist in feto-maternal medicine and is presently head of the obstetric service at the Lausanne University Hospital (CHUV), Switzerland. He is board certified in Obstetrics & Gynecology and operative Gynecology. After his PhD, which focused on the Human Papilloma Virus vaccine, he trained as a postdoc in the institute of Microbiology (CHUV), where he became familiar with chlamydial biology. He then trained at various hospitals worldwide including St-Mary’s Hospital in London, UK (2004-2005), Tu Du Hospital in Saigon/Vietnam (2007, 60,000 deliveries/year), Hopital Necker in Paris (2009-2010), and Mount Sinai Hospital in Toronto (2010-2012); with which he continues active research and clinical collaborations. Thanks to a grant from the “Fondation Leenaards”, David Baud started his own research lab in 2013 before obtaining other peer-reviewed grants and supports including from the Swiss National Science Foundation. His current research focuses on emerging infectious causes of infertility and adverse pregnancy outcomes. Thanks to his clinical expertise in fetal medicine, research expertise in emerging infectious disease and collaborations worldwide, he has also developed a specific interest in emerging viruses (such as SARS-CoV-2 and Zika), with recent publications in the NEJM, The Lancet, The Lancet Infectious Disease, JAMA and BMJ. Baud’s research groups are both involved in clinical and laboratory research.